November 14, 2022

Pathophysiology and management of cardiovascular disease in patients with HIV

Results from several studies have suggested that people with HIV have an increased risk of cardiovascular disease, especially coronary heart disease, compared with people not infected […]
November 14, 2022

Inflammation, immune activation, and cardiovascular disease in HIV

Cardiovascular disease is one of the leading causes of morbidity and mortality in people living with HIV. Several epidemiological studies have shown an increased risk of […]
November 14, 2022

Epidemiology of ischemic heart disease in HIV

Purpose of review The purpose of this review is to summarize and synthesize recent data on the risk of ischemic heart disease (IHD) in HIV-infected individuals. […]
November 14, 2022

HIV-Related Cardiovascular Disease, Statins, and the REPRIEVE Trial

HIV infection is associated with increased cardiovascular disease (CVD), and increased rates of myocardial infarction and stroke have been observed in HIV-infected individuals. After traditional risk […]
November 14, 2022

Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV

People living with human immunodeficiency virus (PLWH) have significantly increased risk for cardiovascular disease in part due to inflammation and immune dysregulation. Clonal hematopoiesis of indeterminate […]
November 14, 2022

Benefits and risks of statin therapy in the HIV infected population

Purpose of review HIV-infected patients face an increased risk for cardiovascular disease (CVD), estimated at 1.5 to 2-fold as compared to HIV uninfected persons. This review […]
November 14, 2022

Statins for primary cardiovascular disease prevention among people with HIV: emergent directions

Purpose of review While people with HIV (PWH) are living longer due to advances in antiretroviral therapy, recent data have demonstrated an increased risk of cardiovascular […]